Article
Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
27 Sept 2006
Abstract excerpt
Current standard cancer therapies (chemotherapy and radiation) often cause serious adverse off-target effects. Drug design strategies are therefore being developed that will more precisely target cancer cells for destruction while leaving surrounding normal cells relatively unaffected. Telomerase, widely expressed in most human cancers but almost undetectable in normal somatic cells, provides an exciting drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
